Ascension’s innovation arm launches $285M venture fund 

Ascension Ventures, the healthcare venture arm of St. Louis-based Ascension, closed a $285 million strategic venture capital fund, bringing the firm’s total assets to more than $1 billion, according to a March 5 news release. 

Advertisement

The new fund is backed by 13 health system partners and is Ascension Ventures’ fifth venture capital fund. Since launching in 2001, Ascension Ventures has invested in almost 80 software, services and medical device and diagnostic companies. 

“This is an important time to be a strategic healthcare investor,” Ascension Ventures Senior Managing Director Matt Hermann said in a news release. “Several factors — the pace of health system transformation, technology advances enabling new care modalities and business models, an influx of seasoned entrepreneurs tackling root cause industry issues — have created a unique time when health system and entrepreneurial markets are aligned.” 

Here are the 13 health system partners that backed the new fund: 

  • AdventHealth (Altamonte Springs, Fla.) 
  • Carle Foundation (Urbana, Ill.) 
  • CentraCare (St. Cloud, Minn.) 
  • Children’s Medical Center of Dallas
  • Intermountain Healthcare (Salt Lake City) 
  • Novant Health (Charlotte, N.C.) 
  • OhioHealth (Columbus) 
  • OSF HealthCare (Peoria, Ill.) 
  • Luminis Health (Annapolis, Md.) 
  • Sentara Healthcare (Norfolk, Va.) 
  • Texas Health Resources (Arlington) 
  • One undisclosed health system

More articles on digital transformation: 
Walgreens expands digital health platform, adds collaborations with Children’s National Hospital, Abbott & more
Humana joins $200M funding round for digital home care provider 
Children’s National Hospital, Johnson & Johnson, Virginia Tech launch health innovation campus

Advertisement

Next Up in Uncategorized

  • Health systems are navigating a rapidly evolving healthcare environment where patient safety is shaped by both longstanding challenges and emerging…

  • Since 2020, CHS has announced or completed the sale of 35 hospitals:  2025 2024 2023 2022 2021 In July 2021,…

  • Sacroiliac joint fusion technology is advancing, and the data shows it’s efficacy across different medtech companies. Five notes: 1. Tenon…

Advertisement

Comments are closed.